This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates-revisions: Archive
Compared to Estimates, Neogen (NEOG) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
NEOGPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
QBTS' 200% Quantum Rally Leaves NVDA, AMD Behind: Can It Lead in 2026?
by Urmimala Biswas
QBTS surged over 200% in 2025, crushing big tech as commercial quantum systems move into real-world deployments.
AAPLNegative Net Change AMDNegative Net Change MSFTNegative Net Change NVDANegative Net Change QBTSNegative Net Change
artificial-intelligence earnings-estimates-revisions earnings-outlook earnings-report tech-stocks
Earnings Estimates Moving Higher for Casey's (CASY): Time to Buy?
by Zacks Equity Research
Casey's General Stores (CASY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CASYPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Scotts (SMG) Upgraded to Buy: Here's Why
by Zacks Equity Research
Scotts (SMG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SMGPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Central Garden (CENTA) Upgraded to Buy: Here's Why
by Zacks Equity Research
Central Garden (CENTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CENTAPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
CyberArk (CYBR) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
CyberArk (CYBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CYBRNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Immunocore (IMCR) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Immunocore (IMCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
IMCRNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Knot Offshore (KNOP) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Knot Offshore (KNOP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
KNOPPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Central Garden (CENT) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Central Garden (CENT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CENTPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Edison International (EIX) Rating Upgrade to Strong Buy
by Zacks Equity Research
Edison International (EIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
EIXPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Morgan Stanley (MS) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes First Western (MYFW) a New Strong Buy Stock
by Zacks Equity Research
First Western (MYFW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MYFWPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Synaptics (SYNA) Upgraded to Buy: Here's Why
by Zacks Equity Research
Synaptics (SYNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SYNANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
WaFd (WAFD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
WaFd (WAFD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WAFDPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
BlackRock (BLK) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BlackRock (BLK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BLKPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
First Horizon National (FHN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
First Horizon (FHN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FHNPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
JB Hunt (JBHT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
JB Hunt (JBHT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JBHTPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Morgan Stanley (MS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Morgan Stanley (MS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MSNegative Net Change CNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Goldman Sachs (GS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Goldman (GS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GSNegative Net Change WFCPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 200.6% upside potential for Inventiva (IVA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
IVANegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 29.22% Upside in Private Bancorp of America (PBAM): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Private Bancorp of America (PBAM) points to a 29.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
PBAMNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 25.83% Upside in Adeia (ADEA): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Adeia (ADEA) points to a 25.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ADEANegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 30.32% Upside in Microsoft (MSFT): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Microsoft (MSFT) points to a 30.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
MSFTNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Viking Therapeutics (VKTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
VKTXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Toll Brothers (TOL) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Toll Brothers (TOL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TOLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth